{"id":3974,"date":"2021-12-10T12:25:00","date_gmt":"2021-12-10T09:25:00","guid":{"rendered":"https:\/\/qafqaztimes.com\/tr\/?p=3974"},"modified":"2021-12-10T16:24:19","modified_gmt":"2021-12-10T13:24:19","slug":"abdde-16-17-yas-grubu-icin-3uncu-doz-pfizer-biontech-asisina-cdcden-onay","status":"publish","type":"post","link":"https:\/\/qafqaztimes.com\/tr\/abdde-16-17-yas-grubu-icin-3uncu-doz-pfizer-biontech-asisina-cdcden-onay\/","title":{"rendered":"ABD&#8217;de 16-17 ya\u015f grubu i\u00e7in 3&#8217;\u00fcnc\u00fc doz Pfizer\/BioNTech a\u015f\u0131s\u0131na CDC&#8217;den onay"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.iha.com.tr\/haber-abdde-16-17-yas-grubu-icin-3uncu-doz-pfizerbiontech-asisina-cdcden-onay-1004688\/#\"><\/a><a href=\"https:\/\/www.iha.com.tr\/haber-abdde-16-17-yas-grubu-icin-3uncu-doz-pfizerbiontech-asisina-cdcden-onay-1004688\/#\"><\/a><a href=\"https:\/\/www.iha.com.tr\/haber-abdde-16-17-yas-grubu-icin-3uncu-doz-pfizerbiontech-asisina-cdcden-onay-1004688\/#\"><\/a><a href=\"\/\/send?text=https%3A%2F%2Fwww.iha.com.tr%2Fhaber-abdde-16-17-yas-grubu-icin-3uncu-doz-pfizerbiontech-asisina-cdcden-onay-1004688%2F Abd'de%20g%C4%B1da%20ve%20ila%C3%A7%20dairesi'nin%20(fda)%20ard%C4%B1ndan%20hastal%C4%B1k%20kontrol%20ve%20%C3%B6nleme%20merkezleri%20(cdc)%20de%2016-17%20ya%C5%9F%20grubu%20i%C3%A7in%20pfizer%2Fbiontech%20a%C5%9F%C4%B1s%C4%B1n%C4%B1n%203'%C3%BCnc%C3%BC%20dozuna%20acil.\"><\/a><strong>ABD\u2019de G\u0131da ve \u0130la\u00e7 Dairesi\u2019nin (FDA) ard\u0131ndan Hastal\u0131k Kontrol ve \u00d6nleme Merkezleri (CDC) de 16-17 ya\u015f grubu i\u00e7in Pfizer\/BioNTech a\u015f\u0131s\u0131n\u0131n 3\u2019\u00fcnc\u00fc dozuna acil kullan\u0131m onay\u0131 verdi.<\/strong><\/p>\n\n\n\n<p>ABD&#8217;de 16-17 ya\u015f grubuna Pfizer\/BioNTech a\u015f\u0131s\u0131n\u0131n 3&#8217;\u00fcnc\u00fc dozunun uygulanmas\u0131na ye\u015fil \u0131\u015f\u0131k verildi. G\u0131da ve \u0130la\u00e7 Dairesi&#8217;nin (FDA) ard\u0131ndan Hastal\u0131k Kontrol ve \u00d6nleme Merkezleri (CDC) de 16-17 ya\u015f grubu i\u00e7in Pfizer\/BioNTech&#8217;in Covid-19&#8217;a kar\u015f\u0131 geli\u015ftirdi\u011fi a\u015f\u0131n\u0131n 3&#8217;\u00fcnc\u00fc dozuna acil kullan\u0131m onay\u0131 verdi.<\/p>\n\n\n\n<p>CDC Direkt\u00f6r\u00fc Dr. Rochelle Walensky yapt\u0131\u011f\u0131 yaz\u0131l\u0131 a\u00e7\u0131klamada, &#8220;Bug\u00fcn, CDC g\u00fc\u00e7lendirici a\u015f\u0131 tavsiyelerini geni\u015fleterek, 16 ya\u015f ve \u00fczerindeki herkesi bir g\u00fc\u00e7lendirici a\u015f\u0131 olmas\u0131 y\u00f6n\u00fcnde te\u015fvik ediyor. Omicron mutasyonu ile ilgili t\u00fcm cevaplara sahip olmasak da, ilk veriler Covid-19 g\u00fc\u00e7lendirici a\u015f\u0131lar\u0131n\u0131n Omicron ve di\u011fer mutasyonlara kar\u015f\u0131 korumaya yard\u0131mc\u0131 oldu\u011funu g\u00f6steriyor. Covid-19 a\u015f\u0131lar\u0131n\u0131n g\u00fcvenli ve etkili oldu\u011funu biliyoruz\u201d dedi.<\/p>\n\n\n\n<p>Walensky, 16-17 ya\u015f grubundaki gen\u00e7lerin ikinci doz a\u015f\u0131lar\u0131ndan en az 6 ay sonra 3&#8217;\u00fcnc\u00fc doz a\u015f\u0131lar\u0131n\u0131 yapt\u0131rabileceklerini duyurdu.<\/p>\n\n\n\n<p>Pfizer\/BioNTech, geli\u015ftirdikleri a\u015f\u0131n\u0131n Omicron mutasyonuna kar\u015f\u0131 y\u00fcksek etki g\u00f6sterdi\u011fini bildirmi\u015f, yap\u0131lan laboratuvar testlerine g\u00f6re Pfizer\/BioNTech a\u015f\u0131s\u0131n\u0131n 3&#8217;\u00fcnc\u00fc dozunun n\u00f6tralize edici antikorlar\u0131 25 kat art\u0131rd\u0131\u011f\u0131 belirtilmi\u015fti.<\/p>\n\n\n\n<p>ABD&#8217;de 16 ve 17 ya\u015f grubunda yakla\u015f\u0131k 4,7 milyon ki\u015fi Covid-19&#8217;a kar\u015f\u0131 tam olarak a\u015f\u0131lan\u0131rken, 2,5 milyondan fazlas\u0131n\u0131n ise ikinci dozu yapt\u0131rmas\u0131n\u0131n \u00fczerinden alt\u0131 ay ge\u00e7ti.<\/p>\n\n\n\n<p><strong>KAYNAK: \u0130ha.com.tr<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ABD\u2019de G\u0131da ve \u0130la\u00e7 Dairesi\u2019nin (FDA) ard\u0131ndan Hastal\u0131k Kontrol ve \u00d6nleme Merkezleri (CDC) de 16-17&hellip;<\/p>\n","protected":false},"author":2,"featured_media":3975,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-3974","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dunya"],"_links":{"self":[{"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/posts\/3974"}],"collection":[{"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/comments?post=3974"}],"version-history":[{"count":1,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/posts\/3974\/revisions"}],"predecessor-version":[{"id":3976,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/posts\/3974\/revisions\/3976"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/media\/3975"}],"wp:attachment":[{"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/media?parent=3974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/categories?post=3974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/tags?post=3974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}